ABBV
☆
EPS:
0.39
Rev:
15.0B
Net Inc:
695M
💾
💾
💾
💾
Income Statement
Balance Sheet
Cash Flow
Revenue
vs Industry
Valuation
Overview
Income Statement
💾
Expenses
💾
Tax
💾
Assets
💾
Assets (Current)
💾
Assets (Non-Current)
💾
Liabilities
💾
Liabilities (Current)
💾
Liabilities (Non-Current)
💾
Cash Flow
💾
Cash Flow Investing
💾
Cash Flow Financing
💾
Dimension Breakdowns
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
abbv:KeyProductPortfolioAxis, srt:ProductOrServiceAxis
Top Products (by latest quarter)
💾
abbv:KeyProductPortfolioAxis, srt:ProductOrServiceAxis, srt:StatementGeographicalAxis
Top Products (by latest quarter)
💾
us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer
abbv:KeyProductPortfolioAxis, srt:ProductOrServiceAxis, srt:StatementGeographicalAxis
Leaf Members
💾
ABBV vs
Drug Manufacturers - General
(6 peers) - Healthcare
Gross Margin
77.6%
+2.3pp vs peers
Operating Margin
24.6%
+14.1pp vs peers
Net Margin
6.9%
-13.3pp vs peers
Gross Margin
Operating Margin
Net Margin
💾
Related:
LLY
AMGN
JNJ
PFE
GILD
BMY
MRK
BIIB
NOVN.SW
AZN.L
